Skip to main content
letter
. 2011 Oct 1;13(10):749–750.

Table 1. Comparison of changes in disease activity by cabergoline and placebo.

Variable Beforecabergoline Aftercabergoline P value Beforeplacebo Afterplacebo P value
Morning stiffness (min) 17.8±28.5 25.6±45.7 1.000 18.3±29.5 30.0±78.8 1.000
Tender joint count 6.7±3.6 2.7±2.3 0.011 3. 9±4.4 3.0±2.9 0.594
Swollen joint count 4.1±2.6 2.0±1.6 0.031 2.7±3.4 1.8±2.8 0.344
Patient assessment of 5. 6±3.5 3.2±2.4 0.047 4.9±3.4 4.1±3.6 0.438
pain (vas)
Patient global assessment 4.67±3.2 2.6±1.8 0.516 4.2±3.3 3.8±3.7 0.625
of disease activity (vas)
ESR (mm/h) 41.0±18.6 29.8±16.1 0.156 24.7±18.3 30.7±23.7 0.438